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Patrick C Y Woo1,2,3,4* and Susanna K P Lau1,2,3,4*Abstract
Background: Emerging human picornaviruses, including human parechovirus (HPeV), Aichi virus (AiV) and salivirus
(SalV) were found to be associated with gastroenteritis, but their roles in enteric infections are not fully understood.
In addition, no report on the circulation of these viruses in Hong Kong is available. The objective of this study was
to investigate the prevalence and genetic diversity of HPeV, AiV and SalV in fecal samples from hospitalized
children with gastroenteritis in Hong Kong.
Methods: Fecal samples from hospitalized children with gastroenteritis were subject to detection of HPeV, AiV and
SalV by RT-PCR using consensus primers targeted to their 5′UTRs. Positive samples were subject to capsid and/or
3CD region analysis for genotype determination. The epidemiology of HPeV, AiV and SalV infections was analyzed.
Results: Among 1,708 fecal samples subjected to RT-PCR using primers targeted to 5′UTR of HPeV, AiV and SalV,
viruses were detected in 55 samples, with 50 positive for HPeV only, 3 positive for AiV only, 1 positive for both HPeV
and AiV, and 1 positive for both HPeV and SalV. Phylogenetic analysis of the partial VP1 gene of the 33 HPeV strains
revealed the presence of genotypes of HPeV- 1, 3, 4, 5, 7, 10, among which HPeV-1 was the predominant genotype
circulating in our population. The peak activity of HPeV infection was in fall. Of the 3 children with AiV infection, the
3 AiV strains were found to belong to genotype A based on the phylogenetic analysis of their partial VP1 and 3CD
regions. The genotype of a SalV strain detected in this study could not be determined. Co-detection of different
pathogens was observed in 24 samples (43.6%) of 55 fecal samples positive for HPeV, AiV and SalV.
Conclusions: HPeV, AiV and SalV were detected in fecal samples of hospitalized children with gastroenteritis in
Hong Kong, with the former having the highest prevalence. HPeV-1 was the predominant genotype among HPeVs,
while genotype A was the predominant genotype among AiVs in this study.
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Picornaviruses are single-stranded positive-sense RNA vi-
ruses that can cause a variety of diseases in humans and an-
imals. Based on genotypic and serological characterization,
picornaviruses are divided into 26 genera, including* Correspondence: pcywoo@hkucc.hku.hk; skplau@hkucc.hku.hk
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unless otherwise stated.Aphthovirus, Aquamavirus, Avihepatovirus, Avisivirus,
Cardiovirus, Cosavirus, Dicipivirus, Enterovirus, Erbovirus,
Gallivirus, Hepatovirus, Hunnivirus, Kobuvirus, Megrivirus,
Mischivirus, Mosavirus, Oscivirus, Parechovirus, Pasivirus,
Passerivirus, Rosavirus, Salivirus, Sapelovirus, Senecavirus,
Teschovirus and Tremovirus (http://www.picornaviridae.
com/). In the past few years, there has been a dramatic in-
crease in the number of novel picornaviruses identified and
genome sequenced [1-12]. Picornaviruses are also well
known for their ability to undergo mutations and recom-
bination, which may lead to the emergence of novel geno-
types associated with increase virulence [13-16].. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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world [17], especially for children below 5 years of age.
Since around 40% of the cases remain undiagnosed [18],
research has been conducted to identify unrecognized
causative agents. Recent advanced molecular techniques
have allowed the discovery of novel viruses including pi-
cornaviruses from patients with gastroenteritis [2,18-22].
Human parechoviruses (HPeVs) have been classified into
16 types (http://www.picornaviridae.com/parechovirus/
hpev/hpev.htm), in which types 1, 3–6, 8, 10 and 11
were found to be associated with gastroenteritis [23-28].
HPeVs have been reported in fecal samples from pa-
tients with gastroenteritis in various parts of the world,
suggesting that the viruses are circulating worldwide
[23-28]. Another picornavirus, Aichi virus (AiV), which
belongs to the genus Kobuvirus, was first isolated from
a patient with oyster-associated gastroenteritis by BS-
C-1 cell culture in Japan in 1989 [29] and its complete
genome sequence was determined in 1998 [21]. Epi-
demiological studies on AiV have demonstrated a global
distribution of this virus [30-37]. Based on phylogenetic
analysis of the sequences between the C-terminus of 3C
and the N-terminus of 3D, AiV isolates were divided
into 3 genotypes: A, B and a newly proposed genotype
C [30,33,36,38]. Most recently, salivirus (SalV) or klas-
sevirus, which belongs to the genus Salivirus, was iden-
tified in pediatric stool samples from patients with
diarrhea [2,39,40]. Based on the results from genomic
characterization, SalV was most closely related to, but
distinct from other members of the genus Kobuvirus.
To date, only few studies reported the molecular epi-
demiology of SalV infection [40-42].
Although previous findings revealed the existence of
HPeV, AiV and SalV, the roles of these viruses in enteric
infections are not fully understood. In addition, no re-
port on the circulation of these viruses in Hong Kong is
available. Therefore, a molecular epidemiological study
was conducted to investigate the prevalence and genetic
diversity of these viruses in the fecal samples from
pediatric patients with gastroenteritis in Hong Kong by re-
verse transcription-polymerase chain reaction (RT-PCR)
using consensus primers targeted to their 5′ untranslated
regions (5′UTRs). Phylogenetic analysis of other gene re-
gions (capsid or 3CD region) was performed to determine
the genotype of the HPeV, AiV and SalV.
Results
Detection of HPeV, AiV and SalV in fecal samples from
pediatric patients with acute gastroenteritis
One thousand four hundred and forty fecal samples
(retrospective study period) and 268 fecal samples (pro-
spective study period) from hospitalized children with
gastroenteritis were screened for the presence of HPeV,
AiV and SalV by RT-PCR using primers targeted to theircorresponding 5′UTR. RT-PCR for HPeV, AiV and SalV
was positive in 55 samples from 49 patients, among
which 52 (3.4% for retrospective, 1.1% for prospective)
from 47 patients contained HPeV, 4 (0.28% for retro-
spective) from 3 patients contained AiV (1 co-detected
in a sample with HPeV strain patient 30/HK/May05) and
1 (0.07% for retrospective) contained SalV (co-detected
in a sample with HPeV strain patient 28/HK/Mar05) by
sequencing and phylogenetic analysis (Figure 1). Among
the 6 patients with multiple detections, the sequences of
the picornavirus strains persistently shed from the same
patient were identical.
The characteristics of the 49 patients with HPeV, AiV
and SalV detected in fecal samples were summarized in
Table 1. The median age of the 47 patients with HPeV
was 17 months (range, 2 months - 8 years). Thirty-
three were male and 14 were female. HPeV was de-
tected nearly throughout the year in the retrospective
period (November 2004 to August 2005, and August to
October 2006), with the highest detection frequency in
fall (Figure 2), while 3 cases of HPeV infection were
identified in September and November 2012, and in
August 2013. HPeV was repeatedly detected in separate
fecal samples from 5 patients (patient 3, 19, 22, 23, and 33).
Diarrheal pathogens were frequently found in the HPeV-
positive fecal samples, with rotavirus identified in 8, noro-
virus in 1, human bocavirus (HBoV) in 2, AiV in 1, SalV in
1, Salmonella enterica serotypes in 5, Campylobacter jejuni
in 1, Staphylococcus aureus in 7, enteropathogenic Escheri-
chia coli in 1, and Aeromonas species in 2.
The median age of the 3 patients with AiV was 2 years
(age range being 8 months - 7 years; M:F =1:2). The 4
AiV positive samples were detected in late winter and
early summer in 2005 (Table 1). AiV was detected in a
7-year-old girl (patient 48) in 2 separate fecal samples
collected on the same day. Co-detection of HPeV was
found in an AiV-positive sample.
For SalV, the virus was detected in the fecal sample
from an 8-year-old girl (patient 28) in March 2005. This
fecal sample was co-detected with HPeV. No AiV and
SalV were detected in fecal samples collected during
September 2012 - August 2013.
Genotyping of HPeV, AiV and SalV strains
To determine the genotype of the HPeV, AiV and SalV
strains detected in this study, amplification and sequen-
cing of their partial VP1 capsid gene and/or 3CD region
were performed. For HPeV, partial VP1 gene of 33 HPeV
strains was successfully amplified and sequenced. A
phylogenetic tree using nucleotide sequences of the par-
tial VP1 gene of HPeV strains detected in Hong Kong
and other HPeV strains with VP1 gene sequences avail-
able in GenBank was constructed (Figure 3). The 33
HPeV strains detected in the present study consisted of
Figure 1 Phylogenetic analysis of partial 5′UTR sequences of (A) HPeV strains from 47 patients, (B) 3 AiV and 1 SalV strains from 4
patients. The trees were inferred from 5′UTR data by the neighbor-joining method, with bootstrap values calculated from 1000 trees. (A) 145
and (B) 188 nucleotide positions in each 5′UTR were included in the analysis. The scale bar indicates the estimated number of substitutions of 20
nucleotides as indicated. The virus strains detected in this study are highlighted in grey. Virus abbreviations (GenBank accession numbers shown
in parentheses): AEV, avian encephalomyelitis virus (NC_003990); AiV, Aichi virus (NC_001918); CPDV, canine picodicistrovirus (JN_819202); DHV1,
duck hepatitis virus 1 (NC_008250); ERBV1, equine rhinitis B virus 1 (NC_003983); FMDV-A, foot-and-mouth disease virus-A (JQ_082983); HAV,
hepatovirus (NC_001489); HCosV-A1, human cosavirus A1 (FJ_4389020); EV-A, human enterovirus A (AY_697458); HPeV2, human parechovirus
type-2 (AJ_005695); PTV1, porcine teschovirus 1 (NC_003985); SafV, saffold virus (EF_165067); SalV, salivirus (GQ_179640); SePV1, seal picornavirus 1
(NC_009891); SSV, simian sapelovirus (AY_064708); SVV, Seneca Valley virus (NC_011349); THV, turkey hepatitis virus (HQ_189775).
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type 4 (3 strains), type 5 (2 strains), type 7 (2 strains)
and type 10 (1 strain), indicating that HPeV-1 was the
predominant genotype circulating in our population.
Among the 5 HPeV-positive patients with multiple de-
tections by RT-PCR targeted to 5′UTR, the partial VP1
gene of the strains shed from 2 of these patients could
be amplified and the partial VP1 sequences of the HPeV
strains from the same patient were found to be identical.
For the genotyping of AiV, the partial VP1 capsid gene
and 3CD region of all 3 AiV strains were amplified and
sequenced. A phylogenetic analysis of nucleotide se-
quences of the partial VP1 gene of AiV showed that 2
AiV strains (AiV patient 1/HK/Feb05 and AiV patient 3/
HK/Jun05) were closely related and formed a clade dis-
tinct from another strain AiV patient 2/HK/May05.
Nevertheless, these 3 AiV strains clustered with geno-
type A strains identified in other countries (Figure 4A).
This was consistent with the phylogenetic result using
nucleotide sequences of the partial 3CD region of AiV(Figure 4B). These findings suggested that only one
genotype, genotype A, of AiV was detected in Hong
Kong in 2005. For the AiV-positive patient with multiple
detections, the partial VP1 and 3CD sequences of AiV
strains shed from the same patient were identical. For
the genotyping of SalV, the partial VP1 gene and 3CD
region of the SalV strain detected in this study could not
be amplified, thus the genotype of this strain cannot be
determined.
Discussion
The present study represented the first to report the de-
tection of HPeV, AiV and SalV in fecal samples from
children with gastroenteritis in Hong Kong. HPeVs were
distributed globally and found to be associated with
acute gastroenteritis [23-28]. A number of studies have
shown that the prevalence of HPeV infections in chil-
dren with diarrhea ranged from 2% - 16.3% in various
countries [19,23,24,43], and it could be as high as 55% in
China [28]. In the present study, the prevalence of HPeV
Table 1 Clinical characteristics and demographic data of the 49 patients with HPeV, AiV and SalV detected in fecal
samples
Patient Month of
detection
Sex Age Virus identified
in this study
Other pathogens detected
from fecal samples
Multiple detections
(days apart)
1 Nov 2004 M 3 HPeV None ND
2 Nov 2004 M 4 m HPeV-1 None ND
3 Nov 2004 F 10 m HPeV-1 None Yes (0)
4 Nov 2004 M 2 HPeV-1 Rotavirus ND
5 Nov 2004 M 2 m HPeV-1 HBoV ND
6 Nov 2004 M 6 m HPeV-1 S. aureus ND
7 Dec 2004 F 1 HPeV None ND
8 Dec 2004 M 7 m HPeV-3 S. aureus, HBoV ND
9 Dec 2004 F 5 m HPeV-1 S. aureus, rotavirus ND
10 Dec 2004 M 2 HPeV-1 Rotavirus ND
11 Dec 2004 M 6 m HPeV None ND
12 Dec 2004 F 10 m HPeV Rotavirus ND
13 Dec 2004 M 2 HPeV-1 None ND
14 Dec 2004 F 1 HPeV-1 None ND
15 Dec 2004 M 1 HPeV None ND
16 Dec 2004 F 6 m HPeV S. aureus ND
17 Dec 2004 M 5 m HPeV-1 None ND
18 Dec 2004 F 3 HPeV-1 Rotavirus ND
19 Dec 2004 M 1 HPeV-1 None Yes (15)
20 Dec 2004 M 8 m HPeV-1 None ND
21 Dec 2004 M 6 m HPeV S. aureus ND
22 Jan 2005 F 1 HPeV-7 None Yes (0)
23 Jan 2005 F 5 m HPeV None Yes (26)
24 Jan 2005 M 5 m HPeV-7 Rotavirus ND
25 Jan 2005 M 9 m HPeV-1 None ND
26 Feb 2005 M 6 m HPeV-1 None ND
27 Feb 2005 M 5 m HPeV-1 None ND
28 Mar 2005 F 8 HPeV-4, SalV None ND
29 Apr 2005 F 1 HPeV-1 Salmonella group B, Campylobacter jejuni ND
30 May 2005 M 2 HPeV-4, AiV Salmonella group B ND
31 May 2005 M 9 m HPeV-3 Aeromonas sobria ND
32 Jul 2005 M 1 HPeV-5 Enteropathogenic E. coli ND
33 Aug 2006 F 7 m HPeV-4 None Yes (5)
34 Aug 2006 M 10 m HPeV-1 S. aureus ND
35 Sep 2006 M 3 HPeV-1 None ND
36 Sep 2006 M 8 m HPeV-5 Salmonella group D ND
37 Sep 2006 F 1 HPeV-1 Salmonella group C ND
38 Sep 2006 M 3 HPeV None ND
39 Oct 2006 M 1 HPeV-10 Rotavirus ND
40 Oct 2006 M 1 HPeV S. aureus, Salmonella group B ND
41 Oct 2006 F 5 m HPeV-1 None ND
42 Oct 2006 M 3 HPeV None ND
43 Oct 2006 M 6 m HPeV None ND
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Table 1 Clinical characteristics and demographic data of the 49 patients with HPeV, AiV and SalV detected in fecal
samples (Continued)
44 Oct 2006 M 2 m HPeV-1 Rotavirus ND
45 Sep 2012 M 7 HPeV-1 Aeromonas veronii biovar sobria ND
46 Nov 2012 M 9 m HPeV Norovirus ND
47 Aug 2013 M 7 HPeV None ND
48 Feb 2005 F 7 AiV None Yes (0)
49 Jun 2005 F 8 m AiV None ND
HBoV, human bocavirus; E. coli, Escherichia coli; S. aureus, Staphylococcus aureus; ND, not done.
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study from Korea but lower than that reported in other
studies [19,23,24,28,43]. HPeV infection was revealed to
predominate in fall, which was in line with other studies
in mainland China and Japan demonstrating that the
highest detection rate of HPeV was noted during the au-
tumn season [25,44]. The reason for the high prevalence
of HPeV during autumn is not known. Further studies
are required to evaluate if temperature and relative
humidity may be important determining factors. Of the
52 samples from 47 patients with HPeV infections, allFigure 2 Seasonality distribution of HPeV, AiV and SalV infections in
2006 and (B) September 2012 to August 2013.showed positive in children who were ≤8 years old, with
the majority (25/47, 53%) being younger than one year
old. This indicated that HPeV infections mainly occurred
in infants and younger children, which was consistent
with the previous findings [23,43]. In one case, a 1-year-
old boy (patient 41) had a hospital-acquired HPeV-1
infection after an operation, suggesting that infection
control measures may be required in controlling nosoco-
mial transmission of HPeV. Another picornavirus, AiV,
has been proposed to be a causative agent of gastro-
enteritis [21]. Several studies have demonstrated that the(A) November 2004 to August 2005 and August 2006 to October
Figure 3 Phylogenetic analysis of the partial VP1 capsid gene of the 33 HPeV strains. The trees were constructed by the neighbor-joining
method, with bootstrap values calculated from 1000 trees. Sequence for 628 nucleotide positions in VP1 gene was included in the analysis. The
scale bar indicates the estimated number of substitutions of 20 nucleotides as indicated. The HPeV strains detected in the present study are
highlighted in grey.
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diarrhea ranged from 0.1% - 4.1% in America, Asia, Europe
and Africa [31,34,37,45-48]. The low prevalence of AiV in-
fections (around 0.2%) in the present study was similar to
that reported in a study from Canada [45]. Although the
present study and most other studies showed low detection
frequency of AiV in clinical specimens of patients withgastroenteritis, a high level of seroprevalence of AiV
(>80%) in adults has been demonstrated [49], suggesting
the widespread of human exposure to AiV during child-
hood. The high seroprevalence together with low detection
rate of AiV in gastroenteritis indicated that AiV infections
are usually asymptomatic or mild. A recently identified
picornavirus, SalV, was found to be associated with
Figure 4 Phylogenetic trees of AiV strains from 3 patients. (A) Sequence for 295 nucleotide position in VP1 gene was included in the
analysis. (B) Sequence for 342 nucleotide positions in partial 3CD region was included in the analysis. The trees are inferred by the neighbor-joining
method with bootstrap value calculated from 1000 trees. The scale bar indicates the estimated number of substitutions of 50 nucleotides as indicated.
The AiV strains detected in the present study are highlighted in grey.
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(<0.1%) in this study was far lower than that reported in
other studies [39,41,42]. In the only available study from
China, SalV was detected in 9 (4.2%) of 216 diarrhea sam-
ples and 0 (0%) of 96 control samples [42]. The differences
in the prevalence of HPeV, AiV and SalV infections among
various countries were probably attributed to different
sampling sources and detection methods (e.g. conventional
RT-PCR, nested RT-PCR and real-time PCR), and varia-
tions in geographic and temporal conditions. While the
present study aims to study the epidemiology of the novel
picornaviruses instead of developing an improved diagnos-
tic assay, it would be interesting to compare our detection
method and other methods in future studies for their per-
formance in diagnosis of HPeV, AiV and SalV infections.
The present data suggested that HPeV-1 was the pre-
dominant genotype among HPeVs, while genotype A
was the predominant genotype among AiVs in Hong
Kong. Phylogenetic analysis using the partial VP1 gene
sequences of HPeV strains revealed that 23 (70%) of 33
typeable HPeV strains were closely related to HPeV-1
strains identified in other countries. In addition to
HPeV-1, other HPeV genotypes, including types 3, 4, 5, 7
and 10, were detected in the present fecal samples. The
low detection frequency of these 5 genotypes was also
noted in previous studies showing that they were the
rare HPeV genotypes identified in fecal samples from
hospitalized patients [24,26,43]. To determine the geno-
type of AiV, the 3CD region of AiV was sequenced.
Since capsid region is also commonly used for genotypicdetermination of other picornaviruses, we also sequenced
the partial VP1 gene for phylogenetic analysis. The clus-
tering pattern in the phylogenetic tree constructed using
the partial VP1 gene sequences of AiV was in agreement
with that using 3CD region (Figure 4). This demonstrated
that genotype of AiV can be well determined by using ei-
ther VP1 or 3CD sequences. The 3 AiV strains in this
study clustered with other known genotype A strains, in-
dicating that only AiV strains of genotype A were circulat-
ing in Hong Kong in 2005. However, we failed to
determine the genotype of the SalV strain from patient 1/
HK/Mar05, which may be due to low viral load in the
samples and/or sequence mismatches between primers
and viral gene sequences.
Co-detection of various diarrheal pathogens by PCR or
culture previously was observed in fecal samples positive
for HPeV in the present study. The frequency of co-
detection in HPeV-positive fecal samples in this study
(46.2%; 24/52) was in line with 2 previous studies from
China showing the co-detection rate ranged from 52.3%-
71.4% in fecal samples of children with acute gastro-
enteritis [44,50], suggesting that co-detection is common
for HPeV. Further studies are required to determine
whether HPeV plays a causative role in these co-infections
or act to exacerbate the disease caused by another patho-
gen. Besides, multiple virus detection was observed in 5
patients with HPeV infection in this study, in which per-
sistent HPeV shedding for more than 2-week period was
noted in fecal samples of patient 19 and patient 23. The
prolonged shedding was probably due to the incomplete
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tients. Further investigation is warranted to examine the
duration of HPeV shedding.
There are several limitations in this study. Firstly, the
difference in epidemiological findings between the retro-
spective and prospective periods might be attributable to
the different sample size (1440 and 268 respectively).
Further study is warranted to collect more fecal samples
for subsequent prospective analysis. Secondly, there is
lack of data for the presence of other enteric viruses in-
cluding enteric adenovirus, sapovirus, torovirus and
astrovirus in the picornavirus-positive fecal samples, so
the co-detection rate might be underestimated. Further
investigation is required to determine if they are present
in the samples. Thirdly, the inclusion of control groups
in future may help examine the association between the
picornaviruses (HPeV, AiV and SalV) and gastroenteritis.
Conclusions
Emerging human picornaviruses including HPeV, AiV
and SalV were detected in fecal samples of children with
acute gastroenteritis in our locality. HPeV is the most
prevailing virus with peak activity in fall in Hong Kong.
The role of AiV and SalV in gastroenteritis remains
uncertain because the number of AiV/SalV-positive sam-
ples was too small in the present study. Routine surveillance
for these viruses in young children with gastroenteritis may
better define their epidemiology and help prevent their
transmission.
Methods
Patients and microbiological methods
A total of 1,708 fecal samples in this study were col-
lected from hospitalized pediatric patients (age <18 years
old) with gastroenteritis, which was defined as the devel-
opment of acute diarrhea with 3 or more loose stools
per day. All samples were obtained from three public
hospitals in Hong Kong. A retrospective study during a
13-month period (November 2004 to August 2005 and
August 2006 to October 2006) and a prospective study
during a 12-month period (September 2012 to August
2013) were conducted. All fecal samples were tested forTable 2 Primers used in this study
Virus Forward primer sequence (5′-3′) Reverse primer sequen
HPeV CCYCTGGGSCCAAAAGSCA GGTACCTYCWGGGCATCC
AiV/SalV CTGAGAMGRYGTTCCGCTGT GACAATTAGCCCAGGSTC
HPeV TCATGGGGTTCNCARATGGA GATACCATAGTGYTTRTAR
AiV TCTTCTCCTTCTACCGCTTG GAGGTGTAGGGGATGGAG
AiV GCCAGTACAAGGACATGCGG CGGTTGACGTTGACGCCA
SalV CCCCRTCAACTTCCAGCAAA ACACGAACGATRGAGGTG
SalV GAGGGCACCGACCTGGATGC TGGTTGATGAGAGAACCAcommon bacterial diarrheal pathogens, rotavirus by anti-
gen detection, norovirus by RT-PCR and HBoV by PCR
[20]. The laboratory results of patients positive for HPeV,
AiV and SalV were analyzed retrospectively. The study
was approved by the Institutional Review Board of the
University of Hong Kong/Hospital Authority Hong Kong
West Cluster.
RNA extraction
Viral RNA was extracted from fecal samples using EZ1
Virus Mini Kit v2.0 (QIAgen, Hilden, Germany). The
RNA was eluted in 60 μl of AVE buffer and was used as
the template for RT-PCR.
RT-PCR for picornaviruses
RT was performed using random hexamers and the
SuperScript III kit (Invitrogen, San Diego, CA, USA) as
described previously [14-16]. PCR for HPeV, AiV and
SalV was performed using two sets of primers designed
by multiple alignments of 5′UTR nucleotide sequences
of the corresponding picornaviruses (Table 2). Each PCR
mixture (25 μl) contained cDNA, PCR buffer, 2 mM
MgCl2, a 200 μM concentration of each deoxynucleoside
triphosphate, and 1.0 U Taq polymerase (Boehringer,
Mannheim, Germany). The mixtures were amplified by
50 cycles of 94°C for 1 min, 55°C for 1 min, and 72°C
for 1 min, with a final extension at 72°C for 10 min. The
amplified products were detected by agarose gel electro-
phoresis. Both strands of PCR products were sequenced
twice with an ABI Prism 3730xl DNA Analyzer (Applied
Biosystems, Foster City, CA, USA), using the PCR
primers. The nucleotide sequences were compared to
the corresponding sequences of other picornaviruses
available in the GenBank.
Phylogenetic analysis
To determine the genotype of HPeV, AiV and SalV de-
tected in fecal samples, partial capsid and/or 3CD regions
of these viruses were amplified and sequenced. Partial
VP1 fragments of HPeV, AiV and SalV were amplified
using three sets of primers designed by multiple align-
ments of VP1 nucleotide sequences of the correspondingce (5′-3′) PCR product size (Target) Purpose
TT 145 bp (5′UTR) Screening of HPeV
AGAT 215 bp (5′UTR) Screening of AiV/SalV
AA 774 bp Amplification of VP1 region
AA 357 bp Amplification of VP1 region
GG 381 bp Amplification of 3CD region
CT 482 bp Amplification of VP1 region
AG 439 bp Amplification of 3D region
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SalV were amplified using two sets of primers designed by
multiple alignment of 3C-3D nucleotide sequences of the
corresponding picornaviruses (Table 2). Both strands of
PCR products were sequenced twice with an ABI Prism
3730xl DNA Analyzer (Applied Biosystems, Foster City,
CA, USA), using the PCR primers. The nucleotide se-
quences of the partial VP1 gene or 3CD region of the virus
strains identified in the present study were compared to
the corresponding sequences of other strains available in
the GenBank. Phylogenetic tree construction was per-
formed using neighbor-joining method with GrowTree
using Kimura’s two-parameter correction, with bootstrap
values calculated from 1000 trees (Genetics Computer
Group, Inc.).
Nucleotide sequence accession numbers
The partial VP1 nucleotide sequences of the HPeV and
AiV strains and 3CD nucleotide sequences of the AiV
strains have been lodged within the GenBank database
under accession numbers KJ796868-KJ796906.
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